ELAN
NYSE · Pharmaceuticals
Elanco Animal Health Inc
$24.90
+0.46 (+1.88%)
Performance
1D
—
1W
—
1M
—
3M
+10.18%
6M
+26.98%
1Y
+136.92%
YTD
+10.57%
Open$24.15
Previous Close$24.44
Day High$25.41
Day Low$24.04
52W High$27.72
52W Low$8.02
Volume—
Avg Volume4.95M
Market Cap11.89B
P/E Ratio—
EPS$-0.48
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$23.56
Above
SMA 200
$18.91
Above
RSI (14)
59.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
22 analysts
Price Target
+595.7% upside
Current
$24.90
$24.90
Target
$173.23
$173.23
$121.49
$173.23 avg
$230.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 4.84B | 4.73B | 2.45B |
| Net Income | -237,947,037 | -209,439,934 | 423.07M |
| Profit Margin | -4.9% | -4.7% | 17.2% |
| EBITDA | 554.80M | 515.46M | 874.42M |
| Free Cash Flow | — | — | 633.64M |
| Rev Growth | +2.3% | +2.3% | +2.6% |
| Debt/Equity | 0.61 | 0.61 | 0.94 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $903.02 | -0.83% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $235.27 | -0.06% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $116.37 | +0.60% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $26.96 | +0.71% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $57.39 | +0.68% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $115.93 | +0.61% | 21.5 | 57.37B |